The FDA has approved ImmunoGen's (IMGN) breast cancer drug TDM1, now called Kadcyla. The...

|By:, SA News Editor

The FDA has approved ImmunoGen's (IMGN) breast cancer drug TDM1, now called Kadcyla. The approval triggers a $10.5M milestone payment to ImmunoGen, with royalties from sales to follow. Shares are halted. (PR)